3.3 C
New York
Wednesday, March 4, 2026

Translational Data Demonstrates Verekitug, a Novel Antibody Antagonist of the TSLP Receptor, Exhibits Increased Potency


Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles